New blood test could catch Cancer's return before symptoms appear
NCT ID NCT03739775
Summary
This study is testing a blood test that looks for tiny pieces of cancer DNA to see if it can detect the return of HPV-related pelvic cancers earlier than current methods. It involves 172 patients who have been treated for these cancers and are now in follow-up care. Researchers will track patients for 2.5 years, comparing the blood test results to standard scans and exams to see if the test accurately predicts a cancer's return.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV POSITIVE PELVIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Pontchaillou
Rennes, 35033, France
-
CHU de Besançon
Besançon, 25030, France
-
Hôpital Tenon
Paris, 75020, France
-
Institut Curie - Paris
Paris, 75005, France
-
Institut Curie - Saint-Cloud
Saint-Cloud, 92210, France
Conditions
Explore the condition pages connected to this study.